bluebird bio, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Revenue:
Product revenue, net
Service revenue
Royalty and other revenue
Product revenue
Other revenue
Total product revenue, net

Collaborative arrangement revenue
Total revenues

Cost of product revenue
Gross margin
Operating expenses:
Selling, general and administrative
Cost of product revenue
Product revenue
Total cost of product revenue

Change in fair value of contingent consideration
Research and development
Restructuring expense
Total operating expenses
Gain from sale of priority review voucher, net
Loss from operations
Interest income, net
Interest income
Interest expense
Other income, net
Loss before income taxes
Income tax benefit (expense)
Net loss from continuing operations
Net loss from discontinued operations
Net loss
Net loss per share - basic and diluted (in dollars per share)
Net loss per share from continuing operations - basic (in dollars per share)
Net loss per share from discontinued operations - basic (in dollars per share)
Net loss per share - basic (in dollars per share)
Net loss per share - diluted (in dollars per share)
Weighted-average number of common shares used in computing net loss per share - basic (in shares)
Weighted-average number of common shares used in computing net loss per share - diluted (in shares)
Other comprehensive income (loss):
Other comprehensive income (loss)
Comprehensive loss

Comments